UNSPSC 51453200: Anthelmintic quinolines

Anthelmintic drugs made from consisting of a catabolite of tryptophan.

UNSPSC 51453200 Anthelmintic quinolines is a Class code showing significant mismatch between its nominal pharmaceutical scope and the actual state and local procurement activity tagged under it. Recent solicitations labeled under this code cover naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, emergency medical supplies for fire rescue operations, and generic multi-source pharmaceuticals and OTC products — none of which are anthelmintic quinolines (antiparasitic agents). The code appears to function as a catch-all for broader pharmaceutical and medical supply procurement rather than a precise product category, with issuing bodies spanning county health departments, state health and human services commissions, municipal fire departments, and multi-state cooperative purchasing alliances. Work being solicited includes recurring supply contracts for emergency medications and medical devices, exploratory market research on pharmacy benefit models, and competitive bidding for consumable medical supplies.

Activity concentrates in Florida, Texas, Minnesota, and Oregon across recent postings. Seminole County, Florida issued IFB 60459723LAS in June 2026 for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries and a two-year initial term plus one-year renewal option. The City of Tampa's Purchasing Department posted ITB 26P00145 in March 2026 for 169 line items of medical and first aid supplies totaling an estimated $700,000 for the Tampa Fire Department Rescue Division, with an SLBE set-aside and 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products, with proposals due March 26, 2026, serving multiple state and local government facilities across participating jurisdictions. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 exploring vendor capabilities for direct-to-manufacturer prescription programs, functioning as preliminary market research prior to formal procurement. The code shows no recent activity aligned with its stated anthelmintic quinoline product definition.